腹腔镜可调节胃束带术对肥胖合并症的中长期影响。
Impact of laparoscopic adjustable gastric banding on obesity co-morbidities in the medium- and long-term.
作者信息
Korenkov M, Shah S, Sauerland S, Duenschede F, Junginger Th
机构信息
Department of Surgery, University of Mainz, Germany.
出版信息
Obes Surg. 2007 May;17(5):679-83. doi: 10.1007/s11695-007-9118-y.
BACKGROUND
The authors evaluated the impact of laparoscopic adjustable gastric banding (LAGB) on obesity-associated diseases in a series at 3 to 8 years postoperatively, namely diabetes, pulmonary disease, hypertension and knee joint pain.
METHODS
145 morbidly obese patients underwent LAGB with mean age 38 years and preoperative BMI 48.5 kg/m2 (range 34-77). Changes in BMI and excess BMI loss (EBL) were evaluated.
RESULTS
138 of the 145 patients (95%) were available for full follow-up. At last follow-up, BMI had dropped to 34.0 +/- 6.4 SD kg/m2, and mean EBL was 61.9 +/- 26.1%. Prevalence of obesity-associated disease was significantly reduced: diabetes decreased from 10% to 4%, treatment-requiring pulmonary disease from 15% to 5%, hypertension from 43% to 27%, and knee pain from 47% to 38%.
CONCLUSION
Following gastric banding, >75% of patients suffering from obesity-related disease had significant decrease or resolution of their co-morbidities.
背景
作者评估了腹腔镜可调节胃束带术（LAGB）对一系列患者术后3至8年肥胖相关疾病的影响，这些疾病包括糖尿病、肺部疾病、高血压和膝关节疼痛。
方法
145例病态肥胖患者接受了LAGB手术，平均年龄38岁，术前体重指数（BMI）为48.5kg/m²（范围34 - 77）。评估了BMI和超重体重减轻（EBL）的变化。
结果
145例患者中有138例（95%）可进行完整随访。在最后一次随访时，BMI降至34.0±6.4标准差kg/m²，平均EBL为61.9±26.1%。肥胖相关疾病的患病率显著降低：糖尿病从10%降至4%，需要治疗的肺部疾病从15%降至5%，高血压从43%降至27%，膝关节疼痛从47%降至38%。
结论
胃束带术后，超过75%患有肥胖相关疾病的患者其合并症显著减轻或得到缓解。
Zotero 插件